Eli Lilly and Co (LLY)
787.02
+23.04
(+3.02%)
USD |
NYSE |
May 15, 16:00
788.15
+1.13
(+0.14%)
After-Hours: 20:00
Eli Lilly Market Cap: 748.54B for May 15, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 14, 2024 | 726.09B |
May 13, 2024 | 720.12B |
May 10, 2024 | 722.31B |
May 09, 2024 | 733.29B |
May 08, 2024 | 736.56B |
May 07, 2024 | 739.20B |
May 06, 2024 | 728.66B |
May 03, 2024 | 698.52B |
May 02, 2024 | 718.42B |
May 01, 2024 | 738.23B |
April 30, 2024 | 742.36B |
April 29, 2024 | 700.64B |
April 26, 2024 | 697.13B |
April 25, 2024 | 688.92B |
April 24, 2024 | 695.89B |
April 23, 2024 | 708.71B |
April 22, 2024 | 695.06B |
April 19, 2024 | 690.29B |
April 18, 2024 | 708.95B |
April 17, 2024 | 713.53B |
April 16, 2024 | 709.70B |
April 15, 2024 | 713.53B |
April 12, 2024 | 714.36B |
April 11, 2024 | 721.92B |
April 10, 2024 | 724.19B |
Date | Value |
---|---|
April 09, 2024 | 719.68B |
April 08, 2024 | 738.74B |
April 05, 2024 | 745.32B |
April 04, 2024 | 729.99B |
April 03, 2024 | 737.50B |
April 02, 2024 | 726.07B |
April 01, 2024 | 722.83B |
March 28, 2024 | 739.66B |
March 27, 2024 | 739.87B |
March 26, 2024 | 736.75B |
March 25, 2024 | 735.08B |
March 22, 2024 | 732.67B |
March 21, 2024 | 732.34B |
March 20, 2024 | 734.81B |
March 19, 2024 | 734.73B |
March 18, 2024 | 725.11B |
March 15, 2024 | 717.04B |
March 14, 2024 | 723.28B |
March 13, 2024 | 720.53B |
March 12, 2024 | 717.78B |
March 11, 2024 | 698.21B |
March 08, 2024 | 724.62B |
March 07, 2024 | 741.75B |
March 06, 2024 | 741.38B |
March 05, 2024 | 739.31B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
102.65B
Minimum
Oct 10 2019
753.27B
Maximum
Mar 04 2024
283.05B
Average
238.04B
Median
Feb 28 2022
Market Cap Benchmarks
Amgen Inc | 171.17B |
Biogen Inc | 34.27B |
Johnson & Johnson | 367.48B |
Vertex Pharmaceuticals Inc | 112.95B |
Viking Therapeutics Inc | 8.604B |
Market Cap Related Metrics
PE Ratio | 117.97 |
PS Ratio | 19.78 |
PEG Ratio | 14.99 |
Price to Book Value | 58.42 |
Price | 787.02 |
Earnings Yield | 0.85% |
PEGY Ratio | 13.91 |
Operating PE Ratio | 59.04 |
Normalized PE Ratio | 77.70 |